经导管二尖瓣瓣膜修復术(TMVR)的全球市场 - 市场规模(各市场区隔)，占有率，法规，偿付，治疗，预测(～2033年)

本报告提供全球经导管二尖瓣瓣膜修復术(TMVR)市场相关调查分析，提供主要企业市场占有率，主要趋势，创新的产品与技术，竞争情形等资讯。

市场模式的主要内容如下列。

已上市的经导管二尖瓣瓣膜修復术(TMVR)的市场与不断变化的竞争格局

• 主要的产业趋势的考察
• 经导管二尖瓣瓣膜修復术(TMVR)市场区隔的年度收益与市场预测(2015年～2033年)
• 有关各市场区隔的整体治疗数，台数，平均销售价格，市场金额的详细的资料

世界，地区，国家层级的市场固有的考察

• 各地区分类的全球趋势之特定市场定性资讯和国家/地区考虑因素
• 经导管二尖瓣瓣膜修復术(TMVR)市场SWOT分析
• 经导管二尖瓣瓣膜修復术(TMVR)市场竞争动态的考察和趋势

透过对医疗保健系统的真实、全面的了解来促进市场理解。市场进入部分还提供有关报销政策和监管环境的信息，使您能够更深入地研究市场动态。

• 各国医疗制度概要
• 各国偿付政策
• 各国医疗技术相关法规形势

对象企业

• Abbott Laboratories
• Edwards Lifesciences Corp
• 其他

Transcatheter Mitral Valve Repair (TMVR) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

Transcatheter mitral valve repair (TMVR) devices are used for minimally invasive treatment of mitral regurgitation (MR). Mitral regurgitation (MR), also known as mitral insufficiency, is caused by insufficient systolic coaptation of the mitral valve leaflets along with a change in the pressure gradient between the atrium and left ventricle. There are two types of MR: degenerative (primary), and functional (secondary). In Europe, transcatheter mitral valve repair (TMVR) is indicated for both primary and secondary MR. Transcatheter Mitral Valve Repair (TMVR) is FDA approved for both primary and secondary MR. Mitral valve repair treatment is preferred over mitral valve replacement in eligible patients because it is linked with lower short-term and long-term mortality and morbidity rates.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Transcatheter Mitral Valve Repair (TMVR) market and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Transcatheter Mitral Valve Repair (TMVR) market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Transcatheter Mitral Valve Repair (TMVR) market.
• Competitive dynamics insights and trends provided Transcatheter Mitral Valve Repair (TMVR) market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abbott Laboratories, Edwards Lifesciences Corp, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Transcatheter Mitral Valve Repair (TMVR) Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Transcatheter Mitral Valve Repair (TMVR) market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Transcatheter Mitral Valve Repair (TMVR) market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Transcatheter Mitral Valve Repair (TMVR) market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.